Sofosbuvir, pegylated interferon, and ribavirin for retreatment of hepatitis C virus genotype 1b following sofosbuvir and ledipasvir failure.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Kalal, C; Shukla, A; Mohanka, R; Vora, M; Patel, P; Shah, S

Published Date

  • May 2018

Published In

Volume / Issue

  • 67 / 5

Start / End Page

  • 2049 - 2050

PubMed ID

  • 29152769

Pubmed Central ID

  • 29152769

Electronic International Standard Serial Number (EISSN)

  • 1527-3350

Digital Object Identifier (DOI)

  • 10.1002/hep.29667

Language

  • eng

Conference Location

  • United States